Patient Name: Clare Deterra 
Age: 42

CC: Chest Pain
HPI: The patient is a 42-year-old female presenting to the Emergency Department with a complaint of chest pain. She describes the pain as a sharp, stabbing sensation located in the center of her chest. The pain started suddenly approximately 2 hours ago while she was at rest. She denies any radiation of the pain, shortness of breath, diaphoresis, or associated symptoms such as nausea and vomiting. She reports no recent illness or trauma. The patient states that she has never experienced a similar episode before.

ROS:
- General: No fever, fatigue, or weight loss.
- Head: No headache or trauma.
- Eyes: No visual changes or eye pain.
- Cardiovascular: No palpitations or leg swelling.
- Pulm: No cough or shortness of breath.
- GI: No nausea, vomiting, or abdominal pain.
- GU: No dysuria or changes in urinary frequency.
- Musculoskeletal: No joint pain or swelling.
- Neurologic: No weakness, numbness, or changes in coordination.
- Endocrine: No excessive thirst or changes in appetite.
- Skin: No rash or skin lesions.

PMHx: 
- Hypertension, diagnosed 5 years ago, being treated with Losartan 50 mg once daily.
- Allergies: None reported.

Medications: 
- Losartan 50 mg once daily for hypertension.
- No other medications reported.

PSurgHx: 
- Appendectomy at age 16.
- No other surgical procedures reported.

FamHx: 
- Family history significant for hypertension in mother and sister.

SocHx: 
- The patient is a non-smoker and denies alcohol or illicit drug use.
- She works as a teacher and has no known occupational exposures.

The patient's vital signs are stable, with a blood pressure of 120/80 mmHg, heart rate of 80 beats per minute, respiratory rate of 16 breaths per minute, temperature of 98.6Â°F, and oxygen saturation of 98% on room air.

Initial investigations include an electrocardiogram and laboratory studies, including a complete blood count, comprehensive metabolic panel, and troponin level measurement. The patient has been placed on a cardiac monitor and given supplemental oxygen via nasal cannula.

Further assessment and management will be based on the results of the investigations and further clinical evaluation.